— Know what they know.
Not Investment Advice

COAG NASDAQ

Hemab Therapeutics Holdings, Inc. Common Stock
1W: -10.4% 1M: -30.4% 3M: +3.8% YTD: -8.5%
$31.11
+0.05 (+0.16%)
 
Weekly Expected Move ±7.4%
$26 $29 $31 $33 $36
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 32 · $1.5B mcap · 24M float · 1.70% daily turnover · Short 69% of daily vol

No ESG data available for COAG

ESG scores are derived from SEC filings (10-K, 10-Q) and may not be available for all companies.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms